Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sirolimus × Dermatologic × Clear all

Phase

Phase 2 7 Phase 1 7 Phase 4 3 Phase 1/2 3 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4 Other hematologic neoplasm 3 Gastrointestinal 3 Myeloid 2 Sarcoma 1 Plasma cell 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Skin Neoplasms 1

Interventions

Dacarbazine 22 Nivolumab 21 pembrolizumab 16 Ipilimumab 16 3-ingenyl angelate 11 Interferon-alpha 10 Imiquimod 10 trametinib 7 aldesleukin 7 Temozolomide 7 dabrafenib 6 cemiplimab 6 Vemurafenib 6 Radiotherapy 6 Introns 6 Interferon alpha-2 6 Fluorouracil 6 methyl 5-aminolevulinate 5 Surgical Procedures, Operative 5 Photochemotherapy 5 Melphalan 5 Interleukin-2 5 Cisplatin 5 Aminolevulinic Acid 5 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Gels 4 Diclofenac 4 Chemotherapy, Adjuvant 4 cobimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05860881 2025-09-09

SiroSkin

Melanoma and Skin Cancer Trials Limited

Phase 3 Active not recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡